0.00Open0.00Pre Close0 Volume0 Open Interest65.00Strike Price0.00Turnover0.00%IV-0.08%PremiumMay 17, 2024Expiry Date78.32Intrinsic Value100Multiplier-2DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma1.83Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Xylem Stock Discussion
Gapping up
$Best Buy(BBY.US)$ stock rose 1.1% after the electronics retailer reported a smaller-than-expected drop in quarterly comparable sales, as deeper discounts encouraged consumers to shop.
$Verizon(VZ.US)$ stock rose 1.5% and AT&T (NYSE:T) stock climbed 1.7% after Citigroup upgraded both telecom giants to ‘buy’ from ‘neutral’, saying they support their dividend yields.
$Oracle(ORCL.US)$ st...
Gap Ups
1. $Azenta(AZTA.US)$ - up 14.9%
2. $Toast(TOST.US)$ - up 12.1%
3. $Celsius Holdings(CELH.US)$ - up 9.6%
4. $Axon Enterprise(AXON.US)$ - up 9.2%
5. $Marqeta(MQ.US)$ - up 7.6%
6. $Akamai(AKAM.US)$ - up 6.1%
7. $Coupang(CPNG.US)$ - up 5.8%
8. $Penn Entertainment(PENN.US)$ - up 5.3%
9...
Avis Budget Group (CAR) has an average rating of Outperform and price targets ranging from $182 to $327, according to analysts polled by Capital IQ.
Wells Fargo Adjusts Price Target on $Ambarella(AMBA.US)$ to $90 From $100, Maintains Overweight Rating
Ambarella (AMBA) has an average outperform rating and a price target range of $70 to...
Jefferies analyst Michael Yee upgraded $Moderna(MRNA.US)$ to Buy from Hold with a price target of $275, up from $170. The shares can rebound in 2023 given the company's pipeline opportunities, Yee tells investors in a research note. He believes Moderna is the "new shiny thing" in personalized cancer vaccine following the recent positive Phase 2 data.
Atlantic Upgrades Warner Music on 'Solid...
Atlantic Equities analyst Richard Radbourne upgraded $Xylem(XYL.US)$ to Overweight from Neutral with a price target of $129, up from $110. Supply chain constraints weighed heavily on Xylem during 2022 but these are now easing and should allow the M&CS business to become an earnings tailwind during fiscal 2023, Radbourne tells investors in a research note.
Micron Initiated Wit...
Cowen analyst Joseph Giordano upgraded $Xylem(XYL.US)$ to Outperform from Market Perform with a price target of $105, up from $85. Survey work suggests municipal budget expansion at least through fiscal 2023 and utility interviews highlight Xylem as well positioned to lead in smart infrastructure, where backlogs are significant and will pace 2023 revenue growth, Giordano tells...
Bernstein analyst Chad Dillard downgraded $Caterpillar(CAT.US)$ to Market Perform from Outperform with a $195 price target. "Several signs point to order growth markedly slowing" in the second half of 2022 then turning negative in 2023 and Caterpillar has become "too reliant in the current environment on pricing to drive growth," Dillard tells investors in a research no...
No comment yet